Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical Trials.

Robert S RosensonDaniel J RaderShazia AliPoulabi BanerjeeJennifer McGinnissRobert Pordy

Published in: Cardiovascular drugs and therapy (2024)

Despite limitations in direct comparisons between study groups, these data indicate that TRL levels could be a future target for lipid-lowering therapies.

Keyphrases

electronic health record
current status
big data
skeletal muscle
metabolic syndrome
deep learning
double blind